Unicycive Therapeutics, Inc. (UNCY)
Nasdaq: UNCY · CIK 0001766140 · United States
Every official Unicycive Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open UNCY filings
Unicycive Therapeutics, Inc. documents
- Unicycive Therapeutics, Inc. 10-K 2026UNCY 10-K 2026: annual report for fiscal 2026
- Unicycive Therapeutics, Inc. 10-K 2025UNCY 10-K 2025: annual report for fiscal 2025
- Unicycive Therapeutics, Inc. 10-K 2024UNCY 10-K 2024: annual report for fiscal 2024
- Unicycive Therapeutics, Inc. 10-K 2023UNCY 10-K 2023: annual report for fiscal 2023
- Unicycive Therapeutics, Inc. 10-K 2022UNCY 10-K 2022: annual report for fiscal 2022
- Unicycive Therapeutics, Inc. 10-Q 2026UNCY 10-Q 2026: quarterly report for fiscal 2026
- Unicycive Therapeutics, Inc. 10-Q 2025UNCY 10-Q 2025: quarterly report for fiscal 2025
- Unicycive Therapeutics, Inc. 10-Q 2024UNCY 10-Q 2024: quarterly report for fiscal 2024
- Unicycive Therapeutics, Inc. 10-Q 2023UNCY 10-Q 2023: quarterly report for fiscal 2023
- Unicycive Therapeutics, Inc. 10-Q 2022UNCY 10-Q 2022: quarterly report for fiscal 2022
- Unicycive Therapeutics, Inc. 8-K 2026UNCY 8-K 2026: current report for fiscal 2026
- Unicycive Therapeutics, Inc. 8-K 2025UNCY 8-K 2025: current report for fiscal 2025
- Unicycive Therapeutics, Inc. 8-K 2024UNCY 8-K 2024: current report for fiscal 2024
- Unicycive Therapeutics, Inc. 8-K 2023UNCY 8-K 2023: current report for fiscal 2023
- Unicycive Therapeutics, Inc. 8-K 2022UNCY 8-K 2022: current report for fiscal 2022
- Unicycive Therapeutics, Inc. DEF 14A 2026UNCY DEF 14A 2026: proxy statement for fiscal 2026
- Unicycive Therapeutics, Inc. DEF 14A 2025UNCY DEF 14A 2025: proxy statement for fiscal 2025
- Unicycive Therapeutics, Inc. DEF 14A 2024UNCY DEF 14A 2024: proxy statement for fiscal 2024
- Unicycive Therapeutics, Inc. DEF 14A 2023UNCY DEF 14A 2023: proxy statement for fiscal 2023
- Unicycive Therapeutics, Inc. DEF 14A 2022UNCY DEF 14A 2022: proxy statement for fiscal 2022
- Unicycive Therapeutics, Inc. Form 4 2026UNCY Form 4 2026: insider trading filing for fiscal 2026
- Unicycive Therapeutics, Inc. Form 4 2025UNCY Form 4 2025: insider trading filing for fiscal 2025
- Unicycive Therapeutics, Inc. Form 4 2024UNCY Form 4 2024: insider trading filing for fiscal 2024
- Unicycive Therapeutics, Inc. Form 4 2023UNCY Form 4 2023: insider trading filing for fiscal 2023
- Unicycive Therapeutics, Inc. Form 4 2022UNCY Form 4 2022: insider trading filing for fiscal 2022
- Unicycive Therapeutics, Inc. S-1 2026UNCY S-1 2026: registration statement for fiscal 2026
- Unicycive Therapeutics, Inc. S-1 2025UNCY S-1 2025: registration statement for fiscal 2025
- Unicycive Therapeutics, Inc. S-1 2024UNCY S-1 2024: registration statement for fiscal 2024
- Unicycive Therapeutics, Inc. S-1 2023UNCY S-1 2023: registration statement for fiscal 2023
- Unicycive Therapeutics, Inc. S-1 2022UNCY S-1 2022: registration statement for fiscal 2022
- Unicycive Therapeutics, Inc. 13F 2026UNCY 13F 2026: institutional holdings for fiscal 2026
- Unicycive Therapeutics, Inc. 13F 2025UNCY 13F 2025: institutional holdings for fiscal 2025
- Unicycive Therapeutics, Inc. 13F 2024UNCY 13F 2024: institutional holdings for fiscal 2024
- Unicycive Therapeutics, Inc. 13F 2023UNCY 13F 2023: institutional holdings for fiscal 2023
- Unicycive Therapeutics, Inc. 13F 2022UNCY 13F 2022: institutional holdings for fiscal 2022
More companies